CLINICAL TRIALS PROFILE FOR TRIMETHOBENZAMIDE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for trimethobenzamide hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00489255 ↗ | Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment | Completed | INC Research Limited | Phase 4 | 2007-05-01 | The purposes of the study are to determine: i. To assess the efficacy of Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine) ii. To determine the optimal duration for continuation of Tigan® following initiation of Apokyn® therapy iii. To assess the safety of Tigan® in combination with Apokyn® iv. To characterize the pharmacokinetic (PK) profile of apomorphine in subjects treated concomitantly with and without Tigan® |
| NCT00489255 ↗ | Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and Treatment | Completed | Ipsen | Phase 4 | 2007-05-01 | The purposes of the study are to determine: i. To assess the efficacy of Tigan® (trimethobenzamide) in preventing nausea and vomiting when initiating therapy with Apokyn® (apomorphine) ii. To determine the optimal duration for continuation of Tigan® following initiation of Apokyn® therapy iii. To assess the safety of Tigan® in combination with Apokyn® iv. To characterize the pharmacokinetic (PK) profile of apomorphine in subjects treated concomitantly with and without Tigan® |
| NCT01770145 ↗ | Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) | Completed | Cape Cod Clinical Research Inc. | Phase 4 | 2012-12-01 | This study is designed to assess the effect of APOKYN treatment in rapid and reliable improvement of motor symptoms in Parkinson's disease (PD) subjects suffering from delayed or unreliable onset of levodopa (L-dopa) action. |
| NCT01770145 ↗ | Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) | Completed | ClinData Services, Inc. | Phase 4 | 2012-12-01 | This study is designed to assess the effect of APOKYN treatment in rapid and reliable improvement of motor symptoms in Parkinson's disease (PD) subjects suffering from delayed or unreliable onset of levodopa (L-dopa) action. |
| NCT01770145 ↗ | Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) | Completed | US WorldMeds LLC | Phase 4 | 2012-12-01 | This study is designed to assess the effect of APOKYN treatment in rapid and reliable improvement of motor symptoms in Parkinson's disease (PD) subjects suffering from delayed or unreliable onset of levodopa (L-dopa) action. |
| NCT02262767 ↗ | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 Co-administered With Trimethobenzamide Hydrochloride in Healthy Subjects | Completed | Pfizer | Phase 1 | 2014-11-01 | This study will test the hypothesis that PF-06649751 with continuous co-administration of trimethobenzamide hydrochloride (TMB) with will be safe and well tolerated. Single doses of PF-06649751 will be tested in this study, starting at a low dose and escalating to a dose projected to be under the current limits for drug concentration. |
| NCT04501211 ↗ | Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis | Withdrawn | Kyowa Kirin | Phase 2 | 2019-01-01 | To determine the efficacy of open -label transdermal patch on chronic nausea and emesis in patients with gastroparesis |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for trimethobenzamide hydrochloride
Condition Name
Clinical Trial Locations for trimethobenzamide hydrochloride
Trials by Country
Clinical Trial Progress for trimethobenzamide hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for trimethobenzamide hydrochloride
Sponsor Name
